الدكتورة أريج غسان مصلح

الدكتورة أريج غسان مصلح

باحث ما بعد الدكتوراه

البريد الإلكتروني

amosleh@hbku.edu.qa

موقع المكتب

D141

الدكتورة أريج غسان مصلح

باحث ما بعد الدكتوراه

المؤهلات العلمية

PhD in Genomics and Precision Medicine

MSc in Genomics and Precision Medicine

الكيان

معهد قطر لبحوث الطب الحيوي

Divison

مركز بحوث الاضطرابات العصبية

السيرة الذاتية

Areej Mesleh is a Postdoctoral Researcher with expertise in neurodegenerative and neurodevelopmental disorders. She graduated with distinction from Qatar University in 2017 and completed her master’s degree in 2019 at Hamad Bin Khalifa University, where she investigated neuroinflammation in Parkinson's disease. Mesleh earned her PhD in 2023, focusing on proteomics in autism spectrum disorder. She is currently working on developing conformation-specific nanobodies against alpha-synuclein as a potential diagnostic and therapeutic tool for Parkinson's disease.

PhD in Genomics and Precision Medicine

Hamad Bin Khalifa University

2023

MSc in Genomics and Precision Medicine

Hamad Bin Khalifa University

2019

BSc in Biomedical Science

Qatar University

2017

Multi-OMICS; Proteomics
Neurodegenerative disorders
Neurodevelopmental disorders
Immunology

Postdoctoral Researcher

Qatar Biomedical Research Institute, Hamad Bin Khalifa University

2024 - Present

>Mesleh, A., Ehtewish, H., de la Fuente, A., Al-Shamari, H., Ghazal, I., Al-Faraj, F., Al-Shaban, F., Abdesselem, H. B., Emara, M., Alajez, N. M., Arredouani, A., Decock, J., Albagha, O., Stanton, L. W., Abdulla, S. A., & El-Agnaf, O. M. A. (2023). Blood proteomics analysis reveals potential biomarkers and convergent dysregulated pathways in autism spectrum disorder: A pilot study. International Journal of Molecular Sciences, 24(8), 7443.

>Mesleh, A., Ehtewish, H., Lennard, K., Abdesselem, H. B., Al-Shaban, F., Decock, J., Alajez, N. M., Arredouani, A., Emara, M. M., Albagha, O., Stanton, L. W., Abdulla, S. A., Blackburn, J. M., & El-Agnaf, O. M. A. (2023). High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder. Frontiers in Molecular Neuroscience, 16, 1222506.

>Ehtewish, H., Mesleh, A., Ponirakis, G., Lennard, K., Al Hamad, H., Chandran, M., Parray, A., Abdesselem, H., Wijten, P., Decock, J., Alajez, N. M., Ramadan, M., Khan, S., Ayadathil, R., Own, A., Elsotouhy, A., Albagha, O., Arredouani, A., Blackburn, J. M., Malik, R. A., & El-Agnaf, O. M. A. (2023). Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia. Frontiers in Neurology, 14, 1256745.

>Al-Absi, E. S., Al-Sadeq, D. W., Younis, M. H., Yassine, H. M., Abdalla, O. M., Mesleh, A. G., Hadwan, T. A., Amimo, J. O., Thalib, L., & Nasrallah, G. K. (2018). Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors. Journal of Medical Microbiology, 67(9), 1302-1309.

Graduated with distinction from QU
GSRA award for postgraduate studies

أعضاء هيئة التدريس

الدكتورة أريج غسان مصلح

الدكتورة أريج غسان مصلح

السيرة الذاتية

المؤهلات العلمية

PhD in Genomics and Precision Medicine

MSc in Genomics and Precision Medicine

BSc in Biomedical Science

الاهتمامات البحثية

الخبرات

Postdoctoral Researcher

المؤلفات المختارة

التكريمات والجوائز